Market Recap — June 29, 2026
Today's running recap of insider activity, SEC filings, and market-moving news. Updates throughout the trading day.
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Kanzhun Authorizes New $1.2B Share Buyback Mandate and Reports $79.6M in Recent Repurchases
Comcast to Spin Off NBCUniversal and Sky in Tax-Free Split, Shares Jump 9%
Brand Engagement Network Joins Russell 2000/3000 Indexes, Secures $7.7M in Q2 Capital
Activist Shareholder Toby Neugebauer Wins Expedited Discovery Against Fermi Board in Proxy Fight
Korn Ferry to Acquire AMS for $1.1 Billion, Creating Global Talent Leader
Sinda Ltd. Finalizes $307M IPO at Premium to Market, Securing Funds for Silver-Gold Exploration
Decoy Therapeutics Secures $3.5M Upfront, Up to $21M Total in Highly Dilutive Private Placement
Restated Q3 2025 Financials Reveal Larger Losses, Severe Going Concern Risk, and Ineffective Controls
Theravance Biopharma Agrees to $17.00/Share Cash Acquisition by Zymeworks, Plus CVR
Major Acquisition: Zymeworks to Buy Theravance Biopharma
MSTR Valued Below Bitcoin Holdings for First Time, Confirms Recent BTC Sale
Solidion Technology Plans SpaceX Stake as Treasury Asset Amid Dire Financial Straits
No high-importance items captured for this date.
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Comcast to Spin Off NBCUniversal and Sky in Tax-Free Split, Shares Jump 9%
Brand Engagement Network Joins Russell 2000/3000 Indexes, Secures $7.7M in Q2 Capital
Korn Ferry to Acquire AMS for $1.1 Billion, Creating Global Talent Leader
Decoy Therapeutics Secures $3.5M Upfront, Up to $21M Total in Highly Dilutive Private Placement
Theravance Biopharma Agrees to $17.00/Share Cash Acquisition by Zymeworks, Plus CVR
Major Acquisition: Zymeworks to Buy Theravance Biopharma
MSTR Valued Below Bitcoin Holdings for First Time, Confirms Recent BTC Sale
Solidion Technology Plans SpaceX Stake as Treasury Asset Amid Dire Financial Straits
High Templar Tech Finalizes Massive 42.8% Share Buyback at $3.20/ADS
Micron Q3 Strength, Memory Shortage Extended Past 2027, Drives Analyst Target Hikes
No notable 8-Ks or news items on this date.
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.